Apparent differences in prostate zones: susceptibility to prostate cancer, benign prostatic hyperplasia and prostatitis
- PMID: 38528290
- DOI: 10.1007/s11255-024-04012-w
Apparent differences in prostate zones: susceptibility to prostate cancer, benign prostatic hyperplasia and prostatitis
Abstract
Men are inevitably plagued by prostate disease throughout their lives. However, the understanding of the pathogenesis of prostate diseases is still limited. In the 1960s, McNeal proposed the theory of prostate zones: the prostate was divided into three main zones: transition zone, central zone, and peripheral zone. Over the past 50 years, significant differences between different prostate zones have been gradually revealed. We summarized the most significant differences in different zones of the prostate. For the first time, we proposed the "apparent difference in prostate zones" concept. This new concept has been proposed to understand the different zones of the prostate better. It also provided new ideas for exploring the susceptibility of lesions in different prostate zones. Despite the reported differences between zones, the treatment of prostate-related diseases remains partition agnostic. Therefore, we also discussed the clinical significance of the "apparent difference in the prostate zone" and emphasized the necessity of prostate zones.
Keywords: Apparent differences; Central zone; Peripheral zone; Prostate; Transition zone.
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
References
-
- Villers A, Steg A, Boccon-Gibod L (1991) Anatomy of the prostate: review of the different models. Eur Urol 20:261–268. https://doi.org/10.1159/000471714 - DOI - PubMed
-
- Foster HE, Barry MJ, Dahm P et al (2018) Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline. J Urol 200:612–619. https://doi.org/10.1016/j.juro.2018.05.048 - DOI - PubMed
-
- Lerner LB, McVary KT, Barry MJ et al (2021) Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline PART I-initial work-up and medical management. J Urol 206:806–817. https://doi.org/10.1097/JU.0000000000002183 - DOI - PubMed
-
- Clemens JQ, Meenan RT, O’Keeffe Rosetti MC et al (2005) Incidence and clinical characteristics of national institutes of health type III prostatitis in the community. J Urol 174:2319–2322. https://doi.org/10.1097/01.ju.0000182152.28519.e7 - DOI - PubMed
-
- Nickel JC, Nyberg LM, Hennenfent M (1999) Research guidelines for chronic prostatitis: consensus report from the first national institutes of health international prostatitis collaborative network. Urology 54:229–233. https://doi.org/10.1016/s0090-4295(99)00205-8 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
